Literature DB >> 28394370

More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party.

M Simonin1, A Dalissier2, M Labopin2, A Willasch3, M Zecca4, A Mouhab5, A Chybicka6, A Balduzzi7, L Volin8, C Peters9, P Bader3, J-H Dalle1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28394370     DOI： 10.1038/bmt.2017.66

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

Review 1.  Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?

Authors:  M Körbling; P Anderlini
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

2.  Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

3.  2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders.

Authors:  Marcelo C Pasquini; Zhiwei Wang; Mary M Horowitz; Robert Peter Gale
Journal:  Clin Transpl       Date:  2010

4.  Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003.

Authors:  M A Pulsipher; J E Levine; R J Hayashi; K W Chan; P Anderson; R Duerst; I Osunkwo; V Fisher; B Horn; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

5.  Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.

Authors:  Mary Eapen; Mary M Horowitz; John P Klein; Richard E Champlin; Fausto R Loberiza; Olle Ringdén; John E Wagner
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

6.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

7.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

Authors:  Craig Kollman; Stephen R Spellman; Mei-Jie Zhang; Anna Hassebroek; Claudio Anasetti; Joseph H Antin; Richard E Champlin; Dennis L Confer; John F DiPersio; Marcelo Fernandez-Viña; Robert J Hartzman; Mary M Horowitz; Carolyn K Hurley; Chatchada Karanes; Martin Maiers; Carlheinz R Mueller; Miguel-Angel Perales; Michelle Setterholm; Ann E Woolfrey; Neng Yu; Mary Eapen
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

8.  Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2015-02-02       Impact factor: 5.483

9.  Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J Kuball; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483

10.  Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.

Authors:  Z S Pavletic; S S Joshi; S J Pirruccello; S R Tarantolo; J Kollath; E C Reed; P J Bierman; J M Vose; P I Warkentin; T G Gross; K Nasrati; J O Armitage; A Kessinger; M R Bishop
Journal:  Bone Marrow Transplant       Date:  1998-01       Impact factor: 5.483
View more
  4 in total

1.  Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.

Authors:  Maria Otth; Christina Schindera; Tayfun Güngör; Marc Ansari; Katrin Scheinemann; Fabiën N Belle; Philipp Latzin; Nicolas von der Weid; Claudia E Kuehni
Journal:  Bone Marrow Transplant       Date:  2020-11-25       Impact factor: 5.483

Review 2.  Haematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukaemia: Special Considerations and Challenges.

Authors:  Charlotte Calvo; Leila Ronceray; Nathalie Dhédin; Jochen Buechner; Anja Troeger; Jean-Hugues Dalle
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

3.  Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Kinga Kwiecinska; Wojciech Strojny; Miroslaw Bik-Multanowski; Marcin Piechota; Walentyna Balwierz
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

4.  Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children's Cancer Hospital Egypt.

Authors:  Mahmoud Hammad; Hanafy Hafez; Iman Sidhom; Dina Yassin; Sherine Salem; Khaled Alsheshtawi; Nayera Hamdy; Nahla Elsharkawy; Alaa Elhaddad
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.